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Abstract
While Papanicolaou (Pap) screening has been implemented since the 1950’s, and is
linked to decreased rates of cervical cancer, national screening rates are still below the national
target screening rate. In Contra Costa County (CCC), the current cervical cancer screening rate is
50.92% (Contra Costa Health Services [CCHS], 2016a). This is far below the national goal of
93% and the first benchmark of 54.33% needed in order to receive state funding under the
California Department of Health Care Services (DHCS) Medi-Cal 2020 waiver. The Medi-Cal
2020 waiver has a 5-year Public Health Incentives and Redesign in Medi-Cal (PRIME) program
requiring participating health systems to complete projects that improve population health, such
as increasing cancer screening rates. CCHS needs to increase screening rates in order to receive
funding from DHCS.
In this paper, the author of this Doctor of Nursing Practice (DNP) project discusses the
design and implementation of an evidence-based cervical cancer screening toolkit to increase
cervical cancer screening rates. The toolkit includes a PowerPoint about the PRIME program and
cervical cancer screening guidelines for Public Health Clinic Services (PHCS) staff, a pocket
reference for cervical cancer screening, and a patient handout.
During the two months following implementation of the toolkit, cervical cancer
screenings for the PHCS pilot group increased when compared to the same time the prior year.
The toolkit helped educate providers and patients, meeting the goal of increasing staff and
patient knowledge about cervical cancer screening. Overall, the toolkit is a cost effective way to
assist the efforts to increase cervical cancer screening rates and obtain Medi-Cal funding.
Keywords: cervical cancer screening, patient education, evidence-based toolkit

INCREASING CERVICAL CANCER SCREENING RATES

3

Acknowledgments
I would like to acknowledge everyone who has supported me throughout my Doctor of
Nursing Practice (DNP) program. I would like to thank my amazing committee chair, Dr. Prabjot
Sandhu for guiding me through the DNP process. Thank you to Dr. Nancy Selix for being on my
committee. You both were there from the very beginning of my FNP education and I could not
imagine two better people to help me finish this journey. Thank you both for your commitment
to my education, support, encouragement, and for pushing me to reach my highest potential.
I would also like to thank Contra Costa Health Services Public Health Clinic Services for
allowing me to implement my DNP project. Thank you to Heather Cedermaz, Arlene Lin,
Michelle Sharman, and Susan Crosby for your continuous support and providing the resources
needed to complete the project. Thank you to the Public Health Clinic Services staff for your
support and participation in this project.
Finally, I would like to thank my parents and sister for their continued love, support, and
encouragement throughout my entire educational career. I would not have gotten to this point
without you.

INCREASING CERVICAL CANCER SCREENING RATES

4

Table of Contents
Section I
Abstract……………………………………………………………………………………2
Acknowledgments…………………………………………………………………………3
Table of Contents……………………………………………………………………….…4
Section II- Introduction……………………………………………………………………….…8
Background and Significance………………………………………………...…….…….8
Setting……………………………………………………………………………….…...10
Local Problem…………………………………………………………………………....11
Intended Improvement…………………………………………………………...….…...11
Review of the Evidence………………………………………………………………….12
Patient Education………………………………………………………………...12
Changing guidelines and adherence……………………………………………...13
Interventions….………………………………………………………………………….16
Conceptual Framework………………………………………………………………......17
Awareness-to-adherence Model………………………………………………… 17
Health Belief Model……………………………………………………………. 18
Theory of Planned Change……………………………………….……………... 19
Section III- Methods ……………………………………………….…………………...……...20
Ethical Issues……………………………………………………………………….…...20
Pilot Project Setting……………………………………………………………………...21
Planning the Intervention………………………………………………………………...21
Toolkit Components……………………………………………………………...22

INCREASING CERVICAL CANCER SCREENING RATES

5

PowerPoint Presentation…………………………………………………22
Pocket Guide……………………………………………………………..22
Patient Handout…………………………………………………...……...23
Initial Strategy………………………………………………………………........23
Cost/Benefit Analysis…………………………………………………………….……...24
Implementation of the Project…………………………………………….……….…….25
Statement of the Work……………………………………………………………….......26
Time Summary………………………………………………………………...................27
Cost Summary………………………………………………………………....................27
Methods of Evaluation…………………………………………………………………...28
SWOT Analysis……………………………………………………………….................29
Return on Investment………………………………………………………………….....30
Analysis………………………………………………………………………………......31
Section IV- Results……………………………………………………………………………...32
Cervical Cancer Screening Rates ………………………………………….……………32
PowerPoint…………………………………………………………………….….……...33
Staff practices ……………………………………………………………….…...33
Scenarios………………………………………………………………………....33
Evaluation of Toolkit Presentation………………………………………………34
Pocket Guide………………………………………………………………......................34
Patient Handout………………………………………………………………..................34
CCHS Screening Rates………………………………………………………………......35
Section V- Discussion………………………………………………………………...................36

INCREASING CERVICAL CANCER SCREENING RATES

6

Summary…………………………………………………….…………………………...36
Relation to Other Evidence………………………………………………………………38
Barriers and Limitations…………………………………………………………...…….39
Interpretation…………………………………………………………………………….40
Section VI- Conclusions………………………………………………………………...............42
Section VII- Funding………………………………………………………………...................42
Section VIII- References………………………………………………………………...…...... 43
Section IX- Appendices………………………………………………………………………...47
Appendix A: PRIME Goals……………………………………………………………...47
Appendix B: PRIME Program Domains…………………………………………………48
Appendix C: Letter of Support from Contra Costa Health Services…………………….49
Appendix D: Johns Hopkins Nursing Evidence-base Practice Rating Scale…………….50
Appendix E: Literature Review………………………………………………………….51
Appendix F: Awareness-to-adherence Model…………………………………………...52
Appendix G: Health Belief Model………………………………………………………53
Appendix H: Kurt Lewin’s Model of Change…………………………………………...54
Appendix I: Statement of Determination………………………………………………. 55
Appendix J: Cervical Cancer Screening PowerPoint………………………...…………. 59
Appendix K: Pocket Guide………………………………………………….…….…….67
Appendix L: Patient Handout……………………………………………………………76
Appendix M: Patient Handout in Spanish ………………………………………………77
Appendix N: Cost Benefit Analysis………………………………………………...……78
Appendix O: Communication Plan………………………………………………………79

INCREASING CERVICAL CANCER SCREENING RATES

7

Appendix P: Pre-Assessment……………………………………………………….……80
Appendix Q: Post-Assessment…………………………………………………………...81
Appendix R: Work Breakdown Structure…………………………………….…………83
Appendix S: GANTT Chart……………………………………………………………...84
Appendix T: Budget………………………………………………………………….… 85
Appendix U: Patient Handout Assessment………………………………………………86
Appendix V: SWOT Analysis………………………………………………………...…87
Appendix W: Comparison of PHCS Provider Screening Rates…………………………88
Appendix X: Results of Pre and Post PowerPoint Staff Assessments…………………...89
Appendix Y: Evaluation of PowerPoint Presentations……………………....…….……90
Appendix Z: Results of Patient Handout Pre and Post Assessments…………….………91

INCREASING CERVICAL CANCER SCREENING RATES

8

Introduction
Background and Significance
Since the introduction of the Papanicolaou (Pap) test in the 1950s, the incidence of and
mortality rates of cervical cancer have decreased significantly in the United States (US).
(Bernard et al., 2014; Vesco et al., 2011; Moyer, 2012). This is due in large part to introduction
of the Pap test in the 1950s, its widespread availability and use, demonstrating the importance of
early, routine, and adequate screening (Vesco et al., 2011). Despite the known benefits of
cervical cancer screening, most recent updates to guidelines, and widespread availability of the
Pap test, screening rates remain low. Data from the 2013 National Institutes of Health Survey
(NIHS) indicates that only 80.7% of women aged 21 to 65 years old report getting a Pap smear
within the past three years (Sabatino et al., 2015). To ensure optimal screening rates, Healthy
People 2020 set the target of 93% for women to receive cervical cancer screening according to
the recommended guidelines (U.S. Department of Health and Human Services, Office of Disease
Prevention and Health Promotion [DHHS], 2016).
The Pap test detects early changes in cervical cells that can lead to cancer if left
untreated. Cervical cancer is one of the slower growing cancers and most commonly diagnosed
in women ages 35 to 44 (National Cancer Institute [NCI], 2016). Cervical cancers begin with
preliminary changes to the cervical cells in its early stages. Early precancerous changes of the
cervix are defined as cervical intraepithelial neoplasias (CIN) and graded in stages, from CIN1 to
CIN3, with CIN3 being carcinoma in situ, meaning the abnormal cells have not extended beyond
the tissues of the cervix. The Pap test provides for examination of cervical cells in order to detect
early abnormal cellular changes, and initiate appropriate treatment before the progression to an
invasive cervical cancer (Vesco et al., 2011). Since precancerous lesions can be detected easily
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and accurately with the Pap test and treated early, most deaths from cervical cancer occur in
women who have not been adequately screened (Moyer, 2012).
Early detection greatly increases the five-year survival rate for women with cervical
cancer. When cervical cancer is diagnosed as localized, meaning it is confined to the part of the
body where it started, the five-year survival rates is 91.3%. If the cancer spreads to a different
part of the body it is staged as regional cancer and the 5-year survival rate is reduced to 57.4%
(NCI, 2016). Cervical cancer often takes several years to develop, which emphasizes why it is
so important to identify pre-cancerous cell changes early (American College of Obstetricians and
Gynecologists [ACOG], 2015). Despite the education regarding the benefits of cervical cancer
screening, nationwide screening rates remain low (Sabatino et al., 2015). Some possible reasons
for low screening rates both nationwide and in CCC are lack of adherence to guidelines by
providers and varying levels of education amongst patients on the importance and benefits of
cervical cancer screening (Brown, Wilson, Boothe, and Harris, 2011; Nolan et al., 2014; Flores
& Acton, 2013; Warren &Thomas, 2011)
Furthermore, in order to receive adequate cervical cancer screening, women must have
access to the health care system. DHCS helps fund health care services for about 13.3 million
Medicaid (referred to as Medi-Cal in California) members (California Department of Health
Care Services [DHCS], 2016a). Medi-Cal waivers are DHCS programs that provide services for
individuals who may not be eligible under Medicaid rules for insurance coverage (DHCS,
2016b). DHCS recently renewed the 5-year Medi-Cal 1115 waiver for 2016 to 2020, which is
called Medi-Cal 2020. Medi-Cal 2020 has four new programs aimed at improving care. One
program is the 5-year Public Health Incentives and Redesign in Medi-Cal (PRIME) program.
PRIME funds are used to remunerate CCHS and other similar safety-net systems for showing
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improvements in ambulatory care (Walker, 2016). The PRIME program has five main goals and
every Designated Public Hospital (DPH) wishing to receive funds must complete projects within
each of three domains: 1) projects that will ensure that patients experience timely access to highquality, efficient, and patient-centered care, 2) targeted high-risk or high-cost populations, and 3)
resource utilization efficiency (Appendices A and B) and achieve specified benchmarks (DHCS,
2016a; Walker, 2016).
Setting
In May 2016, CCHS initiated efforts to meet a multitude of PRIME program goals in
order to receive state funding. While there are several improvement goals for PRIME, this
project aims to meet the PRIME goal of improved cervical cancer screening rates. CCHS
provides care for more than 180,000 low-income residents of Contra Costa County (CCC). Their
mission is to “care for and improve the health of all people in [CCC] with special attention to
those who are most vulnerable to health problems” (CCHS, 2016b). While 13% of CCHS budget
comes from local tax resources the majority, 87%, is supported by federal and state funding
programs, like Medicare and Medi-Cal program grants (CCHS, 2016). After discussions with
managers of the Public Health Clinic Services (PHCS) division at CCHS, the author was able to
identify an opportunity to use educational tools to assist the PRIME Cervical Cancer Screening
team in its efforts to increase CCHS cervical cancer screening rates. The author collaborated
with the stakeholders, who are the leaders of the PRIME Cancer Screening team, Arlene Lin and
Heather Cedermaz, and proposed a project that would help CCHS achieve the cervical cancer
screening PRIME benchmarks. Susan Crosby, Director of Public Health Nursing and PHCS gave
approval with written support of the author’s project addressing PRIME Domain 1 (Appendix
C).
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Local Problem
CCHS is only screening approximately half the women that it should be. At 50.92%, the
current screening rate is far below the national goal of 93%. Many patients who receive care
from CCHS have a large problem list and everything cannot be addressed in one visit.
Designated Primary Care Providers (PCPs) in the Family and Adult Medicine ambulatory clinics
frequently refer the patients on their panel to the Women’s Health clinics to get their cervical
cancer screening. However, the low screening rates suggest that many of these women are not
getting screened at all. This could be due to a variety of factors: difficulty making an
appointment, availability of Women’s Health clinics, burden of coming in for an additional
appointment, lack of understanding about the importance of getting screened, or simply not
wanting to get the screening done. The CCHS patient population is incredibly diverse and
provides care for large minority groups, including African Americans, Hispanics, and Asian
Americans. The diverse patient population indicates the importance of considering the various
beliefs, barriers, and potential interventions among each ethnic group in order to effectively that
increase cervical cancer screening rates, especially in minorities (Nardi, Sandhu, & Selix, 2016).
Intended Improvement
The aim of this project was to systemically address the efforts of the PRIME Cancer
Screening initiative to increase the rates of cervical cancer screenings at CCHS in order to
receive state funding. The first year PRIME benchmark for cervical cancer screening is for
providers to meet a minimum of 54.33% screening of their patient panel who have accessed care
at least twice in the past 12 months. Each year of the five-year PRIME program, the goal is to
increase screening rates by the standard percentage improvement set by DHCS. This is
considered an “improvement over self” target-setting methodology. DHCS will determine this
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based on the current screening rate and the available evidence for what is a reasonable
expectation for clinical change (DHCS, 2016c).
In addition to the possible funding from PRIME, adequate cervical cancer screening is
essential in preventing death, as cervical cancer can be treatable if detected early enough, making
it critical that CCHS make improvements in the screening rates (NCI, 2016). The cervical cancer
screening toolkit was proposed as a way to increase staff and patient awareness and knowledge
about cervical cancer screening and the PRIME program in order to increase screening rates. By
utilizing the current evidence and screening guidelines to educate staff and patients, CCHS can
improve cervical cancer screening rates and obtain funding that will allow CCHS to continue
providing high-quality care to an underserved population.
Review of the Evidence
There are many reasons explored and cited in literature that lead to decreased cervical
cancer screening rates. Many women have a lack of knowledge about cervical cancer and the
screening process. Additionally, providers also express confusion in regards to the guidelines.
Research shows that provider training and patient reminders are successful in increasing cervical
cancer screening. The Johns Hopkins evidence appraisal tool was used to evaluate the strength of
the literature (Appendices D and E). The literature supports the development of the cervical
cancer screening toolkit pilot.
Patient education. The lack of education and knowledge regarding medical procedures,
screening tests, treatments, and therapies can affect an individual’s compliance and interest in
seeking care. Brown, Wilson, Boothe, and Harris (2011) discovered that the majority of women
participating in focus groups had very limited knowledge about cervical cancer. One participant
stated, “Yeah, I know the name, but I don’t know anything about it” (Brown et al., 2011, p. 722).
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There is often a lack of understanding about what testing is being done during the pelvic exam,
with some women thinking the Pap is testing for sexually transmitted infections (STIs) (Nolan et
al., 2014). Women are also unclear if the Pap test is just for detecting cervical cancer or also
detects other female cancers, like uterine or ovarian cancer (Bellinger, Millegan, & Abdalla,
2015). Prior to 2012, multiple organizations had different recommendations for screening
intervals. The changing guidelines cause confusion for patients, making it unclear when they are
supposed to get screened and how often (Nolan et al., 2014; Bellinger et al., 2015).
Moreover, there is inadequate knowledge of the severity of cervical cancer; women did
not resonate with the message that cervical cancer can kill like breast cancer so they did not
place as much importance on cervical cancer screening as they do with getting a mammogram
(Nolan et al., 2014). In contrast, some women believe that cervical cancer is unavoidable. Flores
and Acton (2013) and Warren and Thomas (2011) discovered that many Hispanic women tend to
believe that what happens to them is predetermined and cannot be changed, making them less
likely to have strong health-seeking behaviors like cervical cancer screening. These knowledge
deficits emphasize the need for better patient education about cervical cancer screening,
including the implementation of culturally relevant patient education.
Changing guidelines and adherence. The United States Preventive Services Task Force
(USPSTF) updated the cervical cancer screening guidelines in 2012 to reflect the importance of
cytology and human papilloma virus (HPV) testing. The USPSTF guidelines apply to all women
with a cervix, without a diagnosis of high-grade precancerous cervical lesion, in utero exposure
to diethylstilbestrol (DES), or immunocompromised women, such as those with human
immunodeficiency virus (HIV). Prior to the release of the 2012 guidelines, the USPSTF,
American Cancer Society (ACS) and American College of Obstetrics and Gynecology (ACOG)
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had varied screening recommendations. Now, the USPSTF, ACS, and ACOG jointly recommend
screening with cytology every three years for women 21 to 65 years old. Women 30 to 65 years
old can be screened every five years if they are screened with cytology and HPV testing. The
USPSTF does not recommend screening women older than 65 years old if they have had
adequate screening in the past and are not considered high risk (Moyer, 2012).
Corbelli et al. (2014) surveyed 316 internists, family physicians, and gynecologists at a
large academic institution. Thirty-four percent of providers did not adhere the ACOG’s 2009
guidelines for screening patients under 21 years old, 49% do not adhere to guidelines for age 30
to 65 years old, and 78% did not adhere to the guidelines for women age 21 to 29 years old.
Internists were less likely than family physicians or gynecologists to follow the 2009 guidelines
that recommended less frequent screening. One reason for this may be that internists often refer
their patients to gynecologists for screening and are less aware of when there are guideline
changes. One of the big changes in the 2009 guidelines was less frequent screening intervals and
delaying screening until age 21. Corbelli et al. found that all provider specialties significantly
over screened women in all age groups. This demonstrates the importance of educating providers
about the guidelines and the evidence behind the changes.
Adequate provider knowledge is critical to adherence rates for cervical cancer screening
guidelines. Teoh et al. (2015) conducted a cross-sectional survey to evaluate provider knowledge
of the 2012 USPSTF guidelines in addition to self-reported screening practices in a large health
maintenance organization in Minnesota. The knowledge section had six application questions
about four patient age groups: less than 21 years old, 21 to 29 years old, 30 to 65 years old, and
more than 65 years old. The current practices section consisted of 15 questions about each of the
age categories. There were also questions about their views of how often they adhere to the
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guidelines and reasons for not adhering. Twelve percent of respondents indicated they were not
aware of the updated 2012 guidelines. Of those who were aware of the guidelines, 33% learned
about them from a work e-mail and 51.4% learned about them through their professional
organization. Approximately 88% of providers indicated they would prefer to learn about the
guidelines in an e-mail, while 38.7% prefer to have prompts in the electronic health record
(EHR) system.
Teoh et al. (2015) found that only 5.7% of providers answered all of the screening
scenario questions correctly and 79.8% answered four of the 6 questions correctly. The highest
percentage correct was about screening practices for women with a hysterectomy and no cervix
(99.2%) and the lowest percentage correct was in the 21 to 29-year-old age group (62.9%). The
providers self-reported practices revealed that there is low adherence to the guidelines. Seventyeight percent reported screening ages 21 to 29 correctly with Pap test only every three years and
36.7% screened incorrectly with Pap and HPV co-testing in this age group. Eighty-nine percent
of providers reported accurately screening women ages 30 to 65 years old with Pap test only
every three years, but only 57.4% correctly screen patients with Pap and HPV co-testing every
five years. Most providers stated they did not follow the guidelines because they were not aware
of them. The second most common reason for not following the guideline was that patients
demand different screening intervals. This study exemplifies the need to increase both staff and
patient knowledge of screening guidelines and the evidence behind them.
Prior to the release of concordant guidelines among the different organizations, Han et al.
(2011) studied provider perceptions of having multiple clinical practice guidelines. More than
1,200 providers were surveyed about the ACOG, USPSTF, and ACS guidelines. Han et al. found
that 62% of providers valued having multiple guidelines and favor more aggressive screening
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rather than conservative guidelines. Although the cervical cancer screening guidelines are now
concordant, this study exemplifies the confusion and differing practice decisions that exists when
providers have multiple different guidelines. It is possible that many providers are still following
the 2009 guidelines that favor more frequent screenings. This demonstrates the need for
continued education about the evidence behind the current guidelines.
Interventions. Schwaiger, Aruda, LaCoursiere, Lynch, and Rubin (2013) implemented a
quality improvement project (QIP) at a university of 30,000 students. A total of 24 providers,
including physicians, nurse practitioners, and physician assistants, participated in the QIP to
improve cervical cancer screening rates. In order for providers to effectively integrate new
guidelines into their current practice, they need to understand the evidence behind the guidelines
(Schwaiger et al., 2013). The QIP included a nationally accepted computer module about the
evidence-based science supporting the guidelines and an algorithm for cervical cancer screening
guidelines. The author also created a pocket guide for each provider for easy reference and use as
a teaching tool. After implementation of the study, the percentage of patients screened according
to the guidelines significantly improved from 73.95% to 90.2%. This study demonstrates the
effectiveness of a multi-faceted educational intervention to increase screening rates.
Kaczorowski et al. (2013) studied the effect of provider and patient reminders on cancers
screening rates in Ontario, Canada. Two hundred and thirty-two physicians from 24 different
primary care networks participated in the study. Electronic medical record data was obtained and
integrated to form a reminder list for providers of eligible patients who were due or overdue for
screening. Letters are sent to individual patients to inform them of their health maintenance that
is due. The letters are sent in the patient’s primary language along with educational materials
about the preventive service due. Patient reminder letters had approved text that was individually
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addressed and edited as needed. In addition to the reminder letter, educational materials about the
screenings needed were sent. The materials were available in multiple languages. One year after
implementation of the provider and patient reminders, Pap test rates significantly increased from
68.9% to 75.19%. This study exemplifies the potential increase in screening rates as a result of
provider and patient reminder letters and education about the recommend screening.
Conceptual Framework
The conceptual framework for this project draws on ideals from various learning and
behavior change theories such as the awareness-to-adherence model, the Health Belief Model
(HBM), and Lewin’s theory of Planned Change (TPC), to produce the necessary components of
the toolkit and make the change in CCHS. The awareness-to-adherence model identifies the four
steps that physicians and advanced practice providers (APPs) must progress through as they
work towards complete adherence to new guidelines. The HBM describes six constructs that
contribute to an individual’s preventive health behaviors. The final framework is Lewin’s Theory
of Planned Change (TPC). The TPC describes the process of implementing a change in practice.
Awareness-to-adherence model. Pathman, Konrad, Freed, Freeman, and Koch (1996)
propose a theory that simply having the information does not mean providers will change their
practice. The concept of this model is that there are four steps that providers must go through as
they move towards adopting new guidelines (Appendix F). Before the guideline is released, the
providers are considered to be in a state of pre-awareness (Freed, Pathman, Konrad, Freeman, &
Clark, 1998). The first stage is awareness, which occurs when the guideline is circulated and
providers learn of the new recommendations. It is important to take into consideration how the
information is disseminated as this can affect how successful provider awareness is (Freed et al.,
1998). The second step is agreement, when providers understand and approve of the rationale for
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the guideline (Pathman et al., 1996; Freed et al., 1998). The credibility of the source, benefit of
the new recommendation, complexity of the new recommendation, and acceptance by medical
leaders plays a significant role in provider agreement (Freed et al., 1998). Adoption is the third
step, which occurs when providers start to implement the change into their practice (Pathman et
al., 1996; Freed et al., 1998). The adoption stage tends to take longer if the recommendation is
complex or does not fit well with the current practice (Freed, et al., 1998). The fourth and final
stage is adherence. The provider is considered adherent if the guideline is being consistently
followed in practice (Pathman et al., 1996; Freed et al., 1998). Failure to progress along the path
and complete each stage would prevent full adherence to a new guideline, leading to a need for
creating interventions that will contribute to success at each step (Pathman et al., 1996). At
CCHS many providers are not aware of or are not adhering to the 2012 guidelines. Some patients
are due for screening, but the provider does not do it at the visit or testing is done more
frequently than indicated. CCHS staff members need to learn about the guidelines, the
importance of adhering to the guidelines in order to meet the PRIME benchmarks, and once they
do this, they will fully adhere to them.
Health belief model. The HBM was created in the 1950s by Hochbaum, Rosenstock, and
Kegels as a way to explain the psychology that predicts preventive health behavior. The HBM
has six constructs including: perceived susceptibility, perceived severity, perceived benefits,
perceived barriers, cues to action, and self-efficacy (Appendix G) (Sharma, 2017). Perceived
susceptibility is the belief that an individual has about whether they will get a disease or not as a
result of a particular behavior. Perceived severity is the belief of how much harm will come to
the individual if they were to acquire the disease. Perceived susceptibility and severity can be
grouped together to be called the perceived threat. The higher the perceived threat, the more the
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individual is likely to want to change their behavior to prevent that threat. Perceived benefits
refers to the belief in the advantages of methods to reduce. Perceived barriers are the beliefs
about the monetary or and time costs, actual or imagined, of performing the suggested behavior.
Cues to action are internal or external forces that make an individual feel the need to take action
which are triggered by understanding of perceived benefits and perceived barriers. The last
construct is self-efficacy, which is the confidence an individual has in their ability to perform the
behavior based on the processing of information regarding perceived susceptibility, severity,
benefits, barriers (Sharma, 2017). This theory is frequently used to promote secondary
prevention methods, such as screening for diseases, in order to achieve the desired health
behavior. At CCHS this theory was applied when creating and designing the patient handout and
educating the patients about the importance of getting screened. The handout provided education
about cervical cancer and risk factors to address the perceived susceptibility and severity. It also
provided cues to action to make an appointment and gave them the information needed to make
the appointment on their own.
Theory of planned change. Lewin’s TPC has three components: unfreeze, transition,
and refreeze (Appendix H). According to Shirey (2013), the unfreezing stage entails recognizing
the problem, conducting a gap analysis, and creating a sense of urgency to motivate the team to
make the necessary change to close the gap. The transition phase involves creating a detailed
plan and training that encourages the team to adopt the proposed change. This phase requires
coaching and clear communication that keep the goal at the forefront with an aim for minimal
resistance. The third phase of the TPC is refreezing. This is the stabilization of the change so that
is embedded into the system and can be sustained over time (Shirey, 2013). This is important for
the project as the author needed to motivate CCHS staff to make the change so they could learn
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what they needed to do and then put it into practice. The author used the meeting to present
information about the PRIME initiative and current and target screening rates to unfreeze staff
thinking about cervical cancer screening. The possibility of losing funding if the benchmark is
not met, helped create a sense of urgency to make the change. The presentation and
implementation of the toolkit to unfreeze current thinking. The distribution of the pocket guide
and patient handout in the clinics helped with the transition phase. The refreezing stage is the
ultimate goal, but is not complete at this time.
Methods
Ethical Issues
An overview of the project was submitted to the Doctor of Nursing Practice (DNP)
faculty for approval. The statement of determination was approved as an evidence-based change
project and was determined not to be research with human subjects that would require IRB
approval (Appendix I). No identifying information was recorded from staff or patients.
The author was guided by the ethical principles of beneficence, non-maleficence, and
justice while working on this project to help reduce health disparities (American Nurses
Association, 2016). It is imperative that the patients of this underserved population are treated
with respect, dignity, and the same high-quality of care as those who are able to afford insurance
and the high costs of healthcare. The current screening rates in CCC are far below the national
average. One reason for this may be that the population does not have the same access to care.
CCHS provides low to no-cost health services, but it is important that patients are still receive
the appropriate care. CCHS needs to increase efforts to reach out to patients and ensure they are
receiving adequate screenings.
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Pilot Project Setting
The project was implemented with PHCS, a division of CCHS that provides specialized
clinics in the ambulatory care setting. The PHCS staff operate Women’s Health, Sexually
Transmitted Disease, and Homeless Healthcare clinics that are connected to six ambulatory care
centers throughout CCC. The Homeless Healthcare team also provides homeless outreach in a
mobile health clinic. This enables them to connect homeless patients to care in the health centers,
including cervical cancer screening in Women’s Health or Homeless Healthcare clinics.
Since PHCS staff work at different locations on a daily basis, all staff members meet on
the second Wednesday of every month for four hours. The meetings provide an opportunity to
have all staff together for operations announcements, education and training, and time for each
staff group to break off for role-specific discussions. During the meetings, staff are able to
interface with their managers regarding any concerns at the clinics. Since staff members, are
spread throughout the county on a day-to-day basis, the monthly meeting is the only in-person
communication where all staff are present. The monthly meeting is a common time where
everyone is together to receive practice updates or participating in trainings during the meetings.
That is why the author and the stakeholders decided that the monthly meeting would be the best
time to present the toolkit to PHCS staff.
Planning the Intervention
In order to receive an additional $5 million a year from Medi-Cal for operational funding,
CCHS is obligated to initiate plans to make system changes that will help them meet the PRIME
program benchmarks for care. One key domain of focus in the PRIME program is to improve
overall preventive care services. One of the PRIME project areas was improved cancer
screenings, which includes cervical, breast, and colorectal cancer. The author worked with the
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managers of the PHCS division and identified an opportunity to help improve cervical cancer
screening rates. The cervical cancer screening rates for CCHS are far below the national
screening goal of 93% and CCHS needs to make yearly improvements in the screening rates in
order to receive funding. DHCS set the PRIME benchmark for cervical cancer screening to
increase three percent from the current rate each year.
Toolkit components. After reviewing the literature and from observations in the clinics,
the author proposed the cervical cancer screening toolkit: A PowerPoint presentation, pocket
reference, and patient handout. The purpose was to educate CCHS staff and patients and the plan
was approved by the PRIME Cancer Screening team leaders.
PowerPoint presentation. The author created a PowerPoint presentation that could be
delivered in person and also put on an eLearning system if the pilot was successful. The
PowerPoint was created for presentation to PHCS staff, which includes providers (physicians
and APPs), registered nurses (RNs), and community health workers (CHWs) (Appendix J). The
PowerPoint had six intended outcomes. The first was to gain an understanding of the PRIME
program and what it means for CCHS and receiving funding. The second and third objectives
were to learn what the current screening rates for CCHS are and what the PRIME target goal is.
The fourth objective was to understand the cervical screening tests used and the most recent
United States Preventive Services Task Force (USPSTF) screening guidelines. The fifth
objective was to understand the screening follow-up guidelines. The sixth objective was that the
providers, RNs, and CHWs would gain an understanding of what the PRIME program and effort
to increase cervical cancer screening means for them and their role in the clinic.
Pocket guide. The pocket guide was created for use in the clinics as an easily accessible
reference for staff (Appendix K). The pocket guide contains the 2012 USPSTF cervical cancer
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screening guidelines and algorithms for follow-up management of abnormal Pap smear results.
The guide was placed at the nursing station so the staff could use it when determining when the
patient was due for screening and what follow-up may be necessary if a patient had abnormal
results. The algorithm for abnormal results was created by the University of Missouri
Department of Family and Community Medicine (2014) following the 2012 USPSTF guidelines.
Patient handout. The educational handout for patients was created in order to send
information about cervical cancer screening with a reminder letter about all health care
maintenance that is due for the patient (Appendix L). While the initial plan was for the handout
to be mailed to patients, the author was only able to pilot the handout in the Women’s Health
clinics. The handouts were placed in the Women’s Health clinics so that all women could have
access to the information. The nurses also had the handouts available to distribute to patients
during discharge from appointments for other reasons other than getting a Pap smear. The
handout was also translated into Spanish, which is the most common primary language of
patients after English (Appendix M).
Initial strategy. The initial plan for the project was to pilot the toolkit with the PHCS
providers, RNs, and CHWs. The PowerPoint was going to be tested at the PHCS monthly
meeting, the pocket guides were going to be given to all staff members, and the patient handout
was going to be mailed as a health maintenance reminder letter and also placed in the clinics.
The purpose of the toolkit was to support the efforts of the PRIME Cancer Screening team to
increase cervical cancer screening rates in order to receive state funding. Since the PRIME
program was just starting in May 2016, it was an ideal time for the proposed evidence-based
change. The PRIME Cancer Screening team leaders were enthusiastic about the proposed project
and assisted the author in identifying the objectives and key information to be included in the
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toolkit.
The author was expected to lead the effort to create and implement the toolkit. The author
had previous experience in implementing an evidence-based change project as a Clinical Nurse
Leader student. As a staff nurse with PHCS, the author was familiar with the clinics and how
they function on a daily basis. The PRIME Cancer Screening team leaders provided the
resources to present and print all materials needed for the pilot project.
The author was also responsible for the evaluation of the project. The author chose to
evaluate the increase in cervical cancer screening by comparing rates of two months after
implementation to the same two months the previous year. The author planned to evaluate the
PowerPoint by administering pre- and post-presentation assessments at the meeting. The
effectiveness of the pocket guide was going to be evaluated by staff feedback in addition to the
improved screening rates. The handout was going to be evaluated by asking patients coming in
for cervical cancer screening if they made the appointment because they received a reminder
letter and asked questions about screening to see if the handout was effective.
The author used the agile management method since there were adjustments that needed
to be made to the project along the way (Spundak, 2014). The author frequently interfaced with
stakeholders to ensure the project is on track to meet the goal. The author was ultimately
responsible for addressing any changes to the plan as the project progressed, but continuously
collaborated with the stakeholders for final approval.
Cost/Benefit Analysis
Cervical cancer causes significant financial burden in addition to its effect on quality of
life. There are clear benefits to increasing cervical cancer screening (Appendix N). It is estimated
that national expenditures for cervical cancer care in 2015 were $1.5 billion (NCI, 2015). The
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expenditures vary by the phase of care, with more money being spent on initial care and the last
year of life, and less on continuing care. If abnormalities are detected early and treatment if
initiated early, it is possible to save the $0.2 billion on continued care and $0.7 billion on the
final year of life. Additionally, in 2005 it was estimated that there is a loss of productivity of 1.8
billion dollars in the United States due to cervical cancer deaths (NCI, 2015). In CCHS, a Pap
test costs $180 and HPV co-testing costs $19.50. These numbers demonstrate that for
approximately $200, women can be screened for cervical cancer and HPV.
Cervical cancer screening also has benefits for quality of life. Women with cervical
cancer have a lower median age at presentation than many other cancers. Women who receive
chemotherapy have more symptoms such as sexual dysfunction and urinary and bowel
dysfunction. Another important indicator of quality of life is self-esteem. Those with low selfesteem also have higher anxiety and depression rates, which can lead to more treatment costs
(Chase, Watanabe, & Monk, 2010). These quality of life indicators exemplify the need to screen
for cervical cancer and detect changes early. By doing so, not only can there be reduced care
costs, but women can have improved quality of life.
Implementation of the Project
The author worked closely with the PRIME Cancer Screening team leaders bi-weekly to
monitor and evaluate if the overall goal of the project was being met (Appendix O). The author
monitored the monthly cervical cancer screening rate reports to see if they were increasing and
meeting the goal of 54.33%. The PHCS nurse manager ran all necessary reports and gave them
to the author to analyze.
After creating all the products for the toolkit, the author submitted them to the PRIME
Cancer Screening team leaders for approval. They leaders approved all products and scheduled
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the author to present the toolkit at the PHCS monthly meeting in August 2016. At the monthly
meeting, the author administered assessments before and after the presentation (Appendices P
and Q). The assessments measured confidence in knowledge of the guidelines and level of
adherence to them. They also answered five scenario questions to assess their knowledge of the
guidelines and how to make the decision about when and how to screen. During the presentation
of the educational module, the author also presented the pocket guide and patient handout that
were going to be placed in the clinics. The pre- and post-assessments, presentation of the
PowerPoint, pocket guide, and handout, and question and answer period took approximately one
hour of the monthly meeting. Staff were interactive during the presentation and appreciative of
the training. The patient handout and pocket guide were shown on the projector screen. Staff was
notified that the pocket guides would be available to reference at the nursing station of each
clinic and also e-mailed to them. After piloting the program with the PHCS staff, the author was
invited to present the toolkit to ambulatory care staff at other health centers in the county at the
beginning of 2017.
Statement of the Work
The author was responsible for completing the majority of the work for the project
(Appendix R). The initial stages involved a literature review, formation of the DNP committee,
submitting a statement of determination outlining the project and receiving approval for the
project from the DNP faculty. In order to plan the project, the author evaluated the evidence to
ensure the latest evidence-based research is being used to create the toolkit. The author
developed the project plan, submitted it to the DNP committee and CCHS stakeholders for
approval. Once it was approved, the author created all the elements of the toolkit: The
PowerPoint, pocket guide, and patient handout. Once those materials were all approved by the
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PRIME Cancer Screening team leaders, the author was scheduled to present at the August 2016
PHCS staff meeting. Following the implementation, the author monitored the cervical cancer
screening rates for September through October 2016 and compared them to the September
through October 2015 screening rates.
Time Summary
The timeline of the project is demonstrated using a GANTT chart (Appendix S). The
GANTT chart identified the milestones and expected time of completion in order to help the
author meet the necessary deadlines for a successful implementation of the project. As changes
occurred, the GANTT chart was updated to reflect the current work needed for completion. The
project transpired through a 9-month period, from March 2016 to December 2016. The project
began in March 2016 after discussions with the nurse managers at CCHS PHCS. The author
continuously reviewed the literature for evidence-based research related to the topic. The author
confirmed the Doctor of Nursing Practice (DNP) committee in March and had a change of one
member in May 2016. A statement of determination that outlines the project was presented to the
University of San Francisco DNP faculty for approval. The creation of the deliverables and
implementation of the project took place in July and August 2016. The pilot program was
delivered to the PHCS providers, RNs, and CHWs at the August 2016 monthly meeting.
Following the implementation, the rates of cervical cancer screening pre- and postimplementation were analyzed. The completion of the project with a final presentation to the
author’s university took place in December 2016.
Cost Summary
The project was implemented with a relatively low budget. The total proposed budget
was $12,747.11 and the actual budget was $10,882,73 (Appendix T). The hourly rate used to
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calculate the proposed budget was the average rate for each position. The project required 120
hours of work from the author to assemble the toolkit, implement the project, and evaluate the
impact of the toolkit on cervical cancer screening rate. The author also spent about 15 hours
meeting with the various stakeholders throughout the process. The proposed budget was
calculated based on printing 50 pocket guides and 200 patient handouts and provider time. For
the final implementation, the author printed 10 pocket guides, one for each health center, and 50
patient handouts for the pilot project for a total of $129.44. The total cost for one hour of
provider, RN, and CHW time totaled $1,444.18.
Methods of Evaluation
The evaluation of this DNP project and toolkit consisted of assessing improvements in
cervical cancer screening rates as well as measuring increases in staff and patient knowledge.
The first evaluation method were reports obtained from the PHCS nurse manager of the rates of
screening for September and October 2015. The 2015 rates were compared with the screening
rates from September and October 2016. The expected outcome was that there would be an
increase in cervical cancer screening rates following the implementation of the toolkit. This is
the primary method of evaluation as the overall goal is to increase cervical cancer screening
rates. One potential problem with this evaluation method is that the provider group in 2015 is not
the exact same as the provider group in 2016. There are also systems factors, like the availability
of appointments, and patient accessibility.
The second method of evaluation examined a change in confidence in using the
guidelines and knowledge of how to apply them as a result of the PowerPoint presentation
(Appendices P and Q). The four confidence questions were graded on a 5-point Likert scale, with
1 being strongly disagree and 5 being strongly agree. The author wrote five scenarios for pre-
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and post-module assessments. The scenarios addressed knowledge of the guidelines for each age
group: under age 21 years old, 21 to 29 years old, 30 to 65 years old, over 65 years old, and those
women with a hysterectomy and no cervix. The pre and post-assessments were the same except
the post-assessment included feedback questions about the presentation. The author printed and
handed out the assessments to the staff at the August monthly meeting. The expected outcome
was that there would be an increase in the average confidence in using the guidelines and an
increase in the percentage who answered the scenario questions correctly. This method of
evaluation was created to determine if the PowerPoint was effective in increasing staff
knowledge of the guidelines, but does not evaluate adherence to them in practice. Another issue
with the assessment is that it only captures staff knowledge immediately after the presentation
and does not assess long-term retained knowledge.
The third method of evaluation was the effectiveness of the handout. This was assessed
by evaluating patient knowledge of cervical cancer screening before and after receiving the
patient handout in the clinic. This method changed from the initial plan because the letter was
not mailed to patients during the pilot project timeframe. The author administered pre- and postassessments at randomly selected Women’s Health clinics (Appendix U). The expected outcome
was that there would be an increase in patient knowledge after reviewing the handout. The
evaluations were completed by the end of October 2016.
SWOT Analysis
The author conducted an analysis of the strengths, weaknesses, opportunities, and threats
to the project (Appendix V). There were multiple strengths to the project. One of the main
strengths is that the author had full support from the stakeholders. The timing of the project
coincided with the initiation of the PRIME Cancer Screening team’s needs to increase cervical
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cancer screening rates. Other strengths were the low cost of implementing the project, evidence
that supports the use of a toolkit, and that the author was able to present to all staff at the PHCS
meeting. The most important opportunity was the ability to obtain funding from the Medi-Cal
2020 waiver. Other larger opportunities for the toolkit are improved health outcomes,
distribution of the toolkit to the entire county, and dissemination of the project at other meetings
or as an eLearning module centrally hosted that can be reviewed yearly by all CCHS providers.
Using the DNP student’s model toolkit, other informational toolkits focusing on different areas
of care within the PRIME initiative can be developed. It is also possible to develop initial
toolkits for other preventive care measures, specifically colorectal and breast cancer screening.
Despite the strengths and opportunities, there were also weakness and threats to the
project that needed to be considered. Some of the weaknesses were the inability to control how
many staff members attended the meeting because success of the toolkit would require buy-in
from all staff. Another issue is that the handout will not reach all patients if it is only available in
the clinics. Additionally, the initial implementation was only being piloted with the PHCS staff
and not all of CCHS staff. In order to successfully increase rates to meet the PRIME benchmark,
the toolkit will need to be distributed to all CCHS staff. One of the main threats to the continued
success of the project is that the author will not be present following completion of the project to
continue to update the guidelines; however, it is possible that the author can train an RN to
update the guidelines and patient handouts as needed. Other threats include a lack of staff
interest, the possibility that the staff will not utilize the components of the toolkit or put the
guidelines into practice and that all staff may not complete the training.
Return on Investment
The return on investment for this project is substantial, but not realized at this point in the
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pilot project as the first year of the PRIME program is still in progress. The cost for
implementing is low with the potential to receive $5 million each year for five years by meeting
the screening benchmarks. In addition to the direct return on investment, there are indirect
returns on investment in the improved quality of life for women if abnormalities are detected
earlier and treated with less invasive procedures. This reduces the financial burden of continuing
care and end of life cost in addition to limiting the adverse side effects. Although it has not been
measured at this time or may be difficult to measure, there is a potential cost reduction by
helping to reduce the number of unnecessary Pap tests and unneeded interventions, such as
colposcopy.
Analysis
The expected outcomes of the intervention were increased cervical cancer screening rates
and increased staff and patient knowledge of cervical cancer screening. The primary method of
evaluation was the rate of cervical cancer screening. Overall, for the county, 50.92% of women
21 to 65 years old and have been seen at least two times in the past 12 months are screened
according to the guidelines. Since the pilot program was only done with PHCS staff, the author
obtained reports of cervical cancer screening rates for only PHCS providers in September and
October 2015 and compared them to the post-educational module screening rates in September
and October 2016.
The second method of evaluation is the level knowledge after completing the educational
module. The author used a spreadsheet processing program to input and evaluate the pre- and
post-assessments. The author also analyzed the qualitative responses to the comments section of
the post-assessment in addition to conversations with staff after the presentation.
The third method of evaluation is the increase in patient knowledge after receiving the
handout. The author administered pre- and post-assessments to patients at randomly selected
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PHCS Women’s Health clinics. The author used a spreadsheet processing program to input and
evaluate the change in patient knowledge of cervical cancer. Due to the delay in getting approval
for the handout, the author was only able to gather data from a small sample of English speaking
patients. The Spanish language handout was not utilized as it had not been approved by
translation services by the completion of the pilot period.
Results
Cervical Cancer Screening Rates
The PHCS screening numbers were calculated by adding the total number of screenings
done by each PHCS provider for each month. In 2015, PHCS providers completed cervical
cancer screenings in five CCHS health center. There were 11 providers in September 2015 and
10 in October 2015. In 2016, there were 10 providers in September and 11 providers in October,
screening patients at six health centers. Overall, the total number of cervical cancer screenings
completed by PHCS providers in September and October 2016 following the implementation of
the toolkit increased from the total number of screenings completed in September and October
2015. However, when comparing each month, there was an increase in screenings in September
and a decrease in October when compared to the number of screenings in 2015 (Appendix W). In
September 2015, PHCS providers completed 239 screenings compared to 275 screenings in
September 2016. PHCS providers completed 274 screenings in October 2015 and 251 in October
2016. This is likely due to differences in the 2015 and 2016 staff. Other possible reasons are that
there were more patients scheduling appointments for procedures or other reasons besides
cervical cancer screening, providers seeing less patients as they train newly hired providers, and
patients not coming to their scheduled appointments.
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PowerPoint
Staff practices. The educational module increased staff knowledge of cervical cancer
screening guidelines (Appendix X) The pre- and post-assessment data was entered into an Excel
spreadsheet for analysis. The four confidence questions were graded on a 5-point Likert scale,
with 1 being strongly disagree and 5 being strongly agree. The results indicate that there were
increases in staff confidence in determining when the patient is due for screening, what tests they
need, and that they will be confident in advising the patient when their next screening is due. The
biggest increase from the pre-assessment was in knowledge about the guidelines, from 3.59 to
4.39.
Scenarios. In a pooled survey of 34 staff using the case scenario questions, the results
from the educational module assessments demonstrated an increase in knowledge for four out of
the five questions (Appendix X). Nine providers, 14 RNs, and 11 CHWs attended the
presentation of the toolkit. Scenario question five assessed knowledge about screening patients
under age 21 and when to start screening patients. Seventy-four percent got this question correct
before the module and 88.24% got it correct on the post-assessment. Scenario question six
assessed knowledge of the guidelines for screening women aged 21 to 29 years old. Thirty-three
percent got this question correct before the module and 60.61% got it correct on the postassessment. Scenario question seven assessed knowledge about the screening options for women
ages 30 to 65 years old. This was the question that showed a decrease in the percent who got it
correct, from 37.04% to 29.41%. This question had two correct options and many only chose the
most effective screening method according to the guidelines; however, 88.9% correctly answered
the primary recommendation of Pap test with HPV testing on the post-assessment. Scenario
question eight assessed knowledge about the screening for women over age 65 and when to stop
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screening. Seventy-four percent got the question correct before the module a positive increased
to 91.18% correct was seen on the post-assessment. Scenario question nine evaluated knowledge
of screening guidelines for women with a hysterectomy when the cervix was removed and there
is no history of cervical cancer or dysplasia. Eighty-five percent got this question correct before
the module and 97.06% got it correct on the post-assessment. Overall, the assessments indicate
that knowledge was increased after the educational module.
Evaluation of toolkit presentation. The presentation of the toolkit (Appendix Y) was
well-received by the staff. Staff members were engaged and asked a lot of questions during the
presentation. One staff member wrote, “as a new Community Health Worker, I learned a lot.
Great presentation.” Another wrote, “I never knew about the 5-year guideline, thanks.” One of
the providers wrote, “that was super helpful. I need that information.” One suggestion was that it
would have been helpful to have a handout with the guidelines during the presentation.
Pocket Guide
The pocket guide was well-received by all staff. One RN stated, “We really needed this
since there is always some confusion about what needs to be done.” Overall, all staff members
saw it as useful resource to have available in the clinic.
Patient Handout
The patient handout was effective in increasing patient knowledge of cervical cancer
screening (Appendix Z). After obtaining consent from the patient, the author asked the prehandout questions and then gave the patient the handout while they were waiting for the
provider. At the end of the visit, the author asked the patient the post-handout questions. Despite
the small sample size of only 10 patients, the handout showed increases in knowledge about the
Pap test and HPV in addition to the screening guidelines. The average age of the patients
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surveyed was 41.13 years old. Half of the patients screened were coming in to the clinic
specifically for a Pap test, while the other half had various different visit reasons. The most
frequent reason stated for making the appointment was that they had not had one in years. One
patient stated, “I haven’t had one in years, so I just figured I should come in.” Other reasons for
making a Pap appointment were that their gynecologist told them to or someone called to make
them a Pap test appointment.
Before the handout patient handout, 62.5% of patients had heard of the HPV vaccine, but
only 37.5% knew that it was a risk factor for developing cervical cancer. After the intervention
62.5% correctly identified HPV as the main risk factor for developing cervical cancer. The
patient handout increased knowledge of Pap test only screening intervals of every three years
from 37.5% answering correctly to 75%. None of the patients knew about the five year screening
interval with the Pap and HPV co-test and 75% knew the correct interval after reading the
handout. Finally, 12.5% of patients knew that screening stopped at age 65 years old if there was
no history of abnormal results in the past 20 years and all patients answered it correctly on the
post-assessment.
Patients also answered a question about how they were screened, after receiving the
handout and completing their cervical cancer screening visit. None of the patients knew exactly
how they had been screened, specifically what tests had been done. Two patients stated, “she
didn’t tell me” while two other simply said they did not know. Another patient knew some of the
tests that were done: “Pap gonorrhea, and something else, but I forgot.”
CCHS screening rates. CCHS initiated its efforts to meet the PRIME cervical cancer
screening goal of 54.33% at the end of May 2016. The cervical cancer screening rate in May
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2016 was 51.15%. In September and October 2016, the screening rates increased to 52.32% and
52.59%, respectively.
Discussion
Summary
The pilot implementation of the toolkit over just a 4-month period was successful in
increasing cervical cancer screening rates for PHCS and educating staff and patients about
cervical cancer screening. The success of this pilot program demonstrates the potential to impact
the screening rates and help CCHS achieve the benchmarks needed to obtain PRIME funding if
adequately sustained and enforced or even conducted for a longer period of time. The toolkit is
of value to primary clinical practice because it is a way to ensure all staff members have the
same information and are working towards a common goal of increasing screening rates.
One of the key findings from the staff and patient assessments is that there are significant
knowledge deficits. After the PowerPoint presentation, staff knowledge of guidelines and
confidence in using them increased. Many of the newer employees thought the information was
extremely useful because they were not aware of it. This identifies that there would be a benefit
to having all newly hired employees review the toolkit materials as part of the onboarding
process. It would also be useful to send out occasional reminder e-mails to all staff and if any
updates to the guidelines are released or provide educational modules at quarterly meetings.
The patient handout also helped increase patient knowledge of screening. The patient
survey was incredibly useful for identifying the common misconceptions, knowledge deficits,
and possible reasons for the low screening rates. The patients that mentioned that they did not
know how they were screened because the provider had not told them highlights the need for
improved staff-patient communication during the visit. It may be beneficial going forward for all
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members of the team to make sure the patient is aware of exactly what tests are being done. The
CHW can be specific about what tests the patient will need based on the guidelines as they room
the patient, then the provider can provide education about what the Pap test and HPV test are for
in more detail during the visit, and finally, the RN can answer any further questions about what
testing was done. During discharge, the RN can make sure to let the patient know exactly what
tests were done and when the next screening will be due if everything is normal. They can also
use a technique of providing the handout while the patient is waiting prior to the exam to prepare
them and also allow them to ask questions of their provider as was done during the pilot of the
handout.
The overall increase in cervical cancer screening rates for CCHS and not just for PHCS
providers where the toolkit was piloted indicate that the toolkit was not the only reason for the
increase in screenings from May 2016 through October 2016. However, it can still be a valuable
tool to help increase rates even further if all county staff members are trained and have the
toolkit resources available. Other reasons for the overall CCHS screening rates increase were that
the PRIME Cancer Screening team was sending reminders to providers about the PRIME goals
and current screening rates, staff members were calling patients who were due for screening to
schedule appointments, and staff were combing charts to see which patients on the schedule were
due for screening, regardless of whether or not that was the reason they made the appointment.
The toolkit would be a beneficial way to bolster the efforts to increase cervical cancer screening
rates system wide in order to receive $5 million a year in PRIME funding.
The PowerPoint seemed to be the most effective part of the pilot project. It provided an
opportunity to discuss the PRIME program and its importance for obtaining funding with all
staff. Additionally, the PowerPoint was helpful in making all staff members aware of the
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guidelines. The pocket guide helped supplement what staff learned during the presentation
because there is a quick reference for what needs to be done in the clinic.
In order to sustain these changes in screening rates at CCHS, there needs to be more
education for staff and patients. Staff will need frequent updates and reminders about the most
current guidelines. Additionally, the PRIME Cancer Screening team may need to evaluate the
best way to educate patients and reach patients that are not already scheduled for appointments.
Simply having the handout in the clinics or even mailed out does not guarantee that they will
read the handout or understand everything it says.
After the successful implementation of the cervical cancer screening toolkit, the author
was invited to present to the staff at a monthly meeting at another health center. The plan for
further dissemination is that the author will continue to present at staff meetings over the next
few months. There is also discussion about eventually putting the educational module on an
eLearning system and requiring yearly review for all CCHS providers, RNs, and CHWs.
Relation to Other Evidence
The results of this DNP project are similar to the findings of previous studies. Similar to
what Bellinger et al. (2015), Nolan et al. (2014) and Brown et al. (2011) suggested, the patient
surveys indicated that patients have limited knowledge about cervical cancer, HPV as a risk
factor, and what is done for screening. The pre- and post- PowerPoint presentation assessments
revealed similar findings to the studies of provider adherence to guidelines (Teoh et al., 2015;
Corbelli et al., 2014).
The toolkit was useful in increasing staff knowledge with a PowerPoint presentation and
pocket guide just as Schwaiger et al. (2013) found in their study. The patient handout was
developed because of evidence of the effectiveness of a patient handout in increasing screening
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rates, as demonstrated in the Kaczorowski et al. (2013) study. Though the handout was not
mailed during the pilot phase, the increase in patient knowledge after receiving the handout and
the literature supporting the use of mailed handouts indicate that it would be beneficial to CCHS
efforts to increase screening rates.
Barriers and Limitations
With any project there are barriers, both potential and realized, that must be addressed in
order for implementation to be successful. There were a few potential barriers to implementation
of the toolkit. One concern was getting complete buy-in from the stakeholders. The stakeholders
for this project were the leaders of the PRIME Cancer Screening project for CCHS and the
members of the care team who the project is being designed for. The goal of the project was to
increase cancer screening rates, but all stakeholders may not have believed that an educational
module is necessary. The author addressed this barrier with clear communication about the low
screening rates for providers, explaining the involvement of the entire care team, and the tools
for patient education. However, the author received positive feedback from all members of the
care team. The providers had a slightly lower average score about the usefulness of the toolkit
for their practice, but it was still an agreement that it was useful.
Many of the providers may not want to participate because they believe they are already
aware of the guidelines and practicing correctly. They may also be resistant to having to listen to
another educational presentation. Additionally, other staff members may not understand why
they need to learn about the guidelines. The author emphasized the importance of having the
whole care team on board in order to provide the best preventive care for the patients in addition
by informing the members of the care team about current screening rates and goals.
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There were also barriers with the educational handout for patients. The initial plan was
that the handout would be sent with a reminder letter about health care maintenance that is due.
One barrier here is that many patients do not have a permanent residence so they may not receive
the letter. The author addressed this by having the handouts available in the clinics. However, at
the time of the pilot project, the letter was not yet used for mailing, and the Spanish language
handout was not approved by the translation department for use. Despite this change in the
implementation plan, the author was able to pilot the handouts with a small sample of English
speaking patients in the clinics. This may have provoked limitations to actual results since the
handout was a key piece to reaching patients and involving them actively in making follow up
appointments for screening.
One limitation to the pilot program was that not all PHCS staff members were present at
the meeting. Thirty-four of the 65 PHCS staff members were in attendance at the presentation;
however, the module was emailed to all PHCS staff members for review and the pocket guide
was available for all staff at the clinics. Another issue was that there was some confusion
regarding the guidelines and the current screening practices at CCHS. During the presentation,
one of the providers mentioned that CCHS screens for HPV starting at age 25. The PRIME
Cancer Screening team leader was able to address the discrepancy, but it may have led to
confusion when completing the assessments, specifically question six about how to screening a
26-year-old patient. The author addressed this issue by following up on the CCHS policy and
guideline at the September meeting. CCHS policy is that providers screen patients age 25 to 29
years old with cytology and reflex HPV testing is done if the cytology is abnormal.
Interpretation
The anticipated outcome was that the toolkit would increase cervical cancer screenings
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rates at CCHS and increase staff and patient knowledge of cervical cancer screening guidelines.
Based on the evaluation data, these outcomes were all achieved, indicating that implementation
of the toolkit was successful.
There was an increase in the total number of screenings from 2015 to 2016; however,
there were only 13 more screenings completed in 2016 following implementation of the toolkit
when compared to the same time period the previous year. There were also fewer screenings
done in October 2016 when compared to October 2015. One possible reason for this is that the
provider group in 2015 was not the same as the provider group in 2016. It is also possible that
there were less screenings in October 2016 because the information about PRIME and screening
guidelines was not as fresh in the minds of staff as it was immediately following the
presentation. It may have been beneficial to do a short follow up at the September or October
meeting to remind staff of the tools available and give an update on the PRIME initiative.
The PHCS pilot of the toolkit provided a lot of information about the current level of
knowledge among staff and patients. The results indicate that staff and patients both need
education about cervical cancer screening and that the toolkit components can help increase
knowledge. This supports further dissemination of the toolkit for all providers and clinics. It
would also be beneficial to include the PowerPoint and toolkit components when onboarding
new staff members. The PRIME Cancer Screening team can utilize the toolkit for yearly reviews
of the guidelines and the current screening rates in CCHS. This would help reinforce knowledge
of cervical cancer screening and remind staff about the goals of the PRIME program and the
importance of adequately screening CCHS patients.
The cervical cancer screening toolkit pilot validates that each component has the potential
to increase cervical cancer screening rates in CCHS and improve staff and patient knowledge of
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cervical cancer. The best way to disseminate the toolkit and sustain it would be to load it onto the
eLearning system. If this happens, the educational module for providers, RNs, and CHWs could
be tailored to the specific learning needs of each role. The toolkit will need to be updated and
required for review by new hires and annually or as needed for guideline updates. There is also
an opportunity to further support the PRIME Cancer Screening program by creating toolkits for
colorectal and breast cancer screening.
Conclusions
Cervical cancer screening is essential for early detection and initiation of treatment before
it progresses. CCHS relies heavily on federal and state funding in order to provide services like
cancer screenings for the population of CCC. In order to receive funding from the new Medi-Cal
2020 PRIME program, it was imperative that CCHS undertake projects that would lead to
increased cervical cancer screening rates. The implementation of the educational evidence-based
toolkit that educates staff and patients demonstrated that it can help effectively help increase
cervical cancer screening for CCHS. The toolkit can be modified to include the latest evidence in
order to ensure that CCHS patients are receiving the healthcare services they need in a timely
manner. Similar to previous research demonstrating the effectiveness of using an educational
toolkit, the cervical cancer screening toolkit was an effective way to aid in the effort to increase
cervical cancer screening rates for CCHS.
Funding
The pilot project was funded by the PHCS division of CCHS. The author printed all
pocket guides, handouts, and evaluation tools at the PHCS office. The author did not receive any
compensation for time spent planning, implementing, or evaluating the project.
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Appendix A
PRIME Program Goals

1. Increasing capabilities to
furnish patient-centered,
data-drive, team-based
care to Medi-Cal
beneficiairies, especially
high utlizers or those at risk
of becoming high utilizers.

5. Moving participating
PRIME entities towards
value-based payments
through the adoption of
alternative payment
models

PRIME

4. Improving the ability to
furnish, in the most
appropriate setting, highquality, care that integrates
physical and behavioral
health services and
coordinates care in
different settings for
targeted vulnerable MediCal beneficiaries

2. Improving the capacity
to provide point- of-care
services, complex care
management, and population health management
by strengthening data
analytic capacity to drive
system-level improvement
and culturally competent
care

3. Improve population
health and health
outcomes as evidenced by
the achievement of
performance goals related
to clinical improvements,
effective preventive
interventions, and
improved patient
experience metrics

(California Department of Health Care Services, 2016a)
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Appendix B
PRIME Program Domains

Domain 1:
Projects that will
ensure that
patients
experience timely
access to highquality, efficient,
and patientcentered care

Domain 2:
Targeted HighRisk or High-Cost
Populations.

Domain 3:
Resource
Utilization
Efficiency.

•Projects that will ensure that patients experience timely access
to high-quality, efficient, and patient-centered care
•Patients will receive appropriate preventive services, early
diagnosis and treatment, and will be supported in improving
their ability to care for themselves
•Identify and increase rates of cost-effective standard
approaches to prevention services for a select group of high
impact clinical conditions and populations (cardiovascular
disease, breast, cervical and colorectal cancer, and obesity)

•Projects focused on specific populations that would benefit
most significantly from care integration and alignment
•Attention will be focused on managing and coordinating care
during transitions from inpatient to outpatient and post-acute
settings, to optimize the care experience and outcomes
•Improved Perinatal Care, Care Transitions: Integration of PostAcute Care and Complex Care Management for High Risk
Medical Populations

• Projects that will reduce unwarranted variation in the use
of evidence-based, diagnostics and treatments
(antibiotics, blood or blood products, and high cost
imaging studies and pharmaceutical therapies) targeting
overuse, misuse, as well as inappropriate underuse of
effective interventions.
• Projects will also eliminate the use of ineffective or
harmful targeted clinical services

(California Department of Health Care Services, 2016a)
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Johns Hopkins Nursing Evidence-based Practice Rating Scale
JHNEBP EVIDENCE RATING SCALES
STRENGTH of the Evidence
Level I
Level II
Level III
Level IV
Level V

Experimental study/randomized controlled trial (RCT) or meta analysis of RCT
Quasi-experimental study
Non-experimental study, qualitative study, or meta-synthesis.
Opinion of nationally recognized experts based on research evidence or expert
consensus panel (systematic review, clinical practice guidelines)
Opinion of individual expert based on non-research evidence. (Includes case
studies; literature review; organizational experience e.g., quality improvement
and financial data; clinical expertise, or personal experience)

QUALITY of the Evidence
A

High

Research

consistent results with sufficient sample size, adequate control, and definitive conclusions; consistent
recommendations based on extensive literature review that includes thoughtful reference to scientific
evidence.
Summative
well-defined, reproducible search strategies; consistent results with sufficient numbers of well defined
reviews
studies; criteria-based evaluation of overall scientific strength and quality of included studies; definitive
conclusions.
Organizational
well-defined methods using a rigorous approach; consistent results with sufficient sample size; use of
reliable and valid measures
Expert Opinion expertise is clearly evident
B Good
Research
reasonably consistent results, sufficient sample size, some control, with fairly definitive conclusions;
reasonably consistent recommendations based on fairly comprehensive literature review that includes some
reference to scientific evidence
Summative
reasonably thorough and appropriate search; reasonably consistent results with sufficient numbers of well
reviews
defined studies; evaluation of strengths and limitations of included studies; fairly definitive conclusions.
Organizational
Well-defined methods; reasonably consistent results with sufficient numbers; use of reliable and valid
measures; reasonably consistent recommendations
Expert Opinion expertise appears to be credible.
C Low quality
Research
little evidence with inconsistent results, insufficient sample size, conclusions cannot be drawn
or major
Summative
undefined, poorly defined, or limited search strategies; insufficient evidence with inconsistent results;
flaws
reviews
conclusions cannot be drawn
Organizational
Undefined, or poorly defined methods; insufficient sample size; inconsistent results; undefined, poorly
defined or measures that lack adequate reliability or validity
Expert Opinion expertise is not discernable or is dubious.
*A study rated an A would be of high quality, whereas, a study rated a C would have major flaws that raise serious questions about the
believability of the findings and should be automatically eliminated from consideration.

Newhouse R, Dearholt S, Poe S, Pugh LC, White K. The Johns Hopkins Nursing Evidence-based Practice Rating Scale. 2005. Baltimore, MD,
The Johns Hopkins Hospital; Johns Hopkins University School of Nursing.
© The Johns Hopkins Hospital/The Johns Hopkins University
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Study Design

Qualitative

Qualitative

Nonexperimental
cross-sectional
survey

Author/Year

Bellinger,
Millegan, &
Abdalla, 2015

Brown,
Wilson,
Boothe, &
Harris, 2011

Corbelli et al.,
2014

316 physicians in
internal medicine,
family medicine, and
gynecology in a large
academic hospital
and health clinic
system.

6 focus groups, with
ethnically diverse
black women
recruited from a
federally qualified
health center. 44
women.

3 focus groups, 28
adult African
American women
aged 18 to 70 years
old in South Carolina

Sample Size/Setting

Cross-sectional survey of
physicians in internal
medicine, family
medicine, and
gynecology, assessing
knowledge of cervical
cancer screening
guidelines with short
vignettes.

Use of a focus group
discussion guide to
evaluate knowledge about
HPV and Pap smears,
cervical cancer
prevention, and perceived
barriers to care.
One to two-hour focus
groups assessing the
knowledge and practice of
cervical cancer screening
and identifying the
barriers to screening.

Intervention

There is limited
knowledge and confusion
about cervical cancer
across ethnicities.
Culturally based
interventions and a
strong patient-provider
relationship are important
factors in screening.
A significant proportion
of providers do not
adhere to the current
guidelines. Lack of
knowledge of the
guidelines is the common
reason providers do not
adhere to them.
Adherence varies by
specialty.

Level III;
Quality A

Level III;
Quality B

Evidence
Strength:
Level; Quality
There is a low level of
Level III;
knowledge about cervical Quality B
cancer, risk, and
screening needs.
Findings
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Study Design
Literature
Review

Nonexperimental
survey

Quasiexperimental,
uncontrolled
before and
after study

Author/Year

Flores &
Acton, 2013

Han,
Klabunde,
Breen, Yuan
Garuman,
Davis, &
Taplin, 2011

Kaczorowski,
Hearps,
Lohfeld,
Goeree,
Donald,
Burgess, &
Sebaldt, 2013
90 physicians from 8
primary care network
practices and 156
physicians from 16
family health
network practices
located in
southwestern
Ontario.

1,200 providers

30 articles addressing
health literacy,
Hispanic women, and
cervical cancer
screening

Sample Size/Setting

Combined pay-forperformance incentives
with provider and patient
reminders and deployment
of NPs to enhance the
delivery of Pap tests and
mammograms.

Survey of provider views
of having multiple
discordant screening
guidelines. The survey
assessed knowledge,
attitude, recommendations
and screening practices.

Systematic review of both
quantitative and
qualitative research
conducted using the
following search terms:
cervical smear, Hispanic,
health literacy, and
literacy.

Intervention

Significant increase in
screening rates. 6.3%
increase in Pap test rates
and 5.3% increase in
mammograms over a 1year period.

62% of providers valued
having multiple
guidelines and favor
more aggressive
screening rather than
conservative guidelines.

Providers need to assess
health literacy in order to
adequately improve
cervical cancer
screening. It is necessary
to utilize evidence to
support culturally
appropriate strategies.

Findings

Level III;
Quality A

Level III;
Quality B

Evidence
Strength:
Level; Quality
Level V;
Quality A
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Quasiexperimental,
uncontrolled
before and
after study

24 providers (13
MDs, 9 NPs, and 2
PAs) at a New
England public
university of 30,000
students treating
women 18 to 29
years old

2014

Dai, Chow,
Christie, &
Mangione,

Schwaiger,
Aruda,
LaCoursiere,
Lynch, &
Rubin, 2013

Sample Size/Setting
64 participants in
hospitals, health
centers, and
community-based
centers in Boston,
MA.

Study Design

Nolan,
Qualitative
Renderos, Xue

Author/Year
Six 90-minute focus
groups. 1 with black
women from the general
population, 1 group of
black cervical cancer
survivors, one with
community leaders in
women’s health, and three
with health care providers.
Moderator guides with
open-ended questions.
The ones for women was
about their knowledge,
barriers, and experiences.
The ones for community
leaders and providers
asked the same questions
and questions about their
experiences serving
patients.
Improving provider
adherence to cervical
cancer screening
guidelines with a provider
computer education
module and pocket guide
The providers completed
pre and post surveys, in
addition to chart audits.

Intervention

Significant increase in
guideline-consistent
cervical cancer screening
following the
intervention.

Inadequate education and
information for patients
and providers creates
barriers. There are
emotional and cultural
barriers that affect
screening practices.
Insurance coverage
affects screening and
follow-up. The patientprovider relationship
affects screening,
treatment, follow-up, and
quality of care. Followup after an abnormal Pap
is a challenge.

Findings

Level V;
Quality B

Evidence
Strength:
Level; Quality
Level III;
Quality B
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Nonexperimental
cross-sectional
survey

Teoh,
Marriott,
Vogel,
Marriott, Lais,
Downs, &
Kulasingham,
2015

Warren &
Literature
Thomas, 2011 Review

Study Design

Author/Year

N/A

124 providers
(physicians, nurse
practitioners,
physicians assistants,
and certified nurse
midwives)

Sample Size/Setting

Review of literature about
the reasons for low
cervical cancer screening
rates for low-English
proficiency (LEP)
Hispanic women and the
effect of LEP and how
Nurse Practitioners can
address these issues.

Cross-sectional survey of
providers assessing
knowledge of cervical
cancer screening
guidelines, self-reported
screening practices, and
reasons for not adhering.

Intervention

There are many
knowledge deficits and
cultural beliefs that affect
cervical cancer screening
practices among LEP
Hispanic women. It is
important for providers
to be aware of cultural
beliefs, especially
fatalism, and provide
linguistically congruent
care.

Level V;
Quality B

Evidence
Strength:
Level; Quality
Knowledge of guideline
Level III;
appropriate screening and Quality A
adherence to the
guidelines is poor. Poor
adherence is most
commonly a result of not
being aware of the
guidelines. Patient
demands are another
reason for nonadherence.
Findings
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Appendix F
Awareness-to-Adherence Model

Preawareness
Awareness
Agreement
Adoption
Adherence

(Pathman et al., 1996)

INCREASING CERVICAL CANCER SCREENING RATES

56

Appendix G
Health Belief Model

Perceived
Susceptibility

Perceived
Severity

Perceived
Benefits

Health
Behavior
Pervceived
Barriers

Cues to Action

Self-Efficacy

(Sharma, 2016)
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Appendix H
Kurt Lewin’s Model of Change

• Ensure
readiness for
change

Unfreeze

Change
• Execute the
intended
change

• Enusres that the
change
becomes
permanent

Refreeze

(Mullins, 2013)
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Statement of Determination
DNP Project Approval Form: Statement of Determination
Student Name:__Christina Nardi_______________________

Title of Project: Using multi-modal education in a Public Health System, to increase rates of
Cervical Cancer screening
Brief Description of Project:
A) Aim Statement: This project will promote Increased rates of cervical cancer screening over a
3-month period through an evidence-based educational cervical cancer screening toolkit at
Contra Costa Health Services (CCHS).
B) Description of Intervention: Creation and implementation of an evidence-based educational
cervical cancer screening toolkit for providers and patients. The toolkit will include an eLearning
educational module for providers (physicians and Advanced Practice Providers), nurses, and
medical assistants about the cervical cancer screening guidelines, the algorithm for cervical
cancer screening according to the most current guidelines, and a handout for patients about
cervical cancer screening. The eLearning module will be piloted with the Public Health Clinic
Services group in person, during the monthly meeting. Following the pilot, the PRIME Cancer
Screening team will decide if any changes need to be made before loading it as and eLearning
module for all CCHS Clinical Services care team members.
C) How will this intervention change practice? The current cervical cancer screening rates in
the CCHS are below the standard of 60%. The goal is that providers will screen a minimum of
60% of their patient panel that are supposed to be screened according to the current guidelines.
The median screening rate for providers is currently 40%. Research shows that adequate cervical
cancer screening is essential to preventing death as it can be treatable if detected early enough.
Research also indicates that patient/provider collaboration can increase screening rates. The
toolkit will help educate providers and patients in order to increase knowledge about cervical
cancer screening and make the patients more informed so they can be more proactive in getting
appropriate screenings done. This should lead to an increase cervical cancer screening rates.
D) Outcome measurements:
1. PHCS Cervical cancer screening rates pre and post implementation of the toolkit.
2. Assessment of PHCS staff knowledge of cervical cancer screening guidelines pre and post
implementation of the toolkit.
3. Assessment of patient knowledge of cervical cancer screening guidelines, pre and post
implementation of the toolkit.
To qualify as an Evidence-based Change in Practice Project, rather than a Research Project, the
criteria outlined in federal guidelines will be used: (http://answers.hhs.gov/ohrp/categories/1569)
This project meets the guidelines for an Evidence-based Change in Practice Project as
outlined in the Project Checklist (attached). Student may proceed with implementation.
This project involves research with human subjects and must be submitted for IRB approval
before project activity can commence. Comments:
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Appendix J
Cervical Cancer Screening PowerPoint

Objectives
• Understand
• Review

CCHS

Cervical Cancer
Screening

the Medi-Cal 2020 PRIME Program

of the current cervical cancer screening rates for

• Learn

the target screening rate required to meet the
PRIME benchmark

• Understand

the current screening methods and
guidelines for cervical cancer screening

Improving rates in CCHS

• Cervical
• Your

cancer screening follow up recommendations

role in promoting screening

PRIME Program
• Contra

Costa County receives 87% of funding from federal
and state funding programs.1

• The

California Department of Health Care Services
(DHCS) helps fund health care services for about 13.3
million Medi-Cal members.2

PRIME Program

• Medi-Cal

waivers are DHCS programs that provide
services for individuals who may not be eligible under
Medicaid rules.3

Public Health Incentives and Redesign in Medi-Cal
•

The DHCS recently renewed the 5-year Medi-Cal 1115
waiver for 2016 to 2020, which is called Medi-Cal 2020.
(Cont.)

PRIME Goals

PRIME Program cont.
• Medi-Cal

2020 has four new programs aimed at improving
care. One program is the 5-year Public Health Incentives
and Redesign in Medi-Cal (PRIME) program.

• PRIME

funds will be used to compensate CCHS and other
similar safety-net systems for showing improvements in
ambulatory care.4

• PRIME

has five main goals and every Designated Public
Hospital (DPH) wishing to receive funds must complete
projects within each of three domains and achieve specified
benchmarks.2,4
(Cont.)

1. Increasing capabilities to furnish patient-centered,
data-drive, team-based care to Medi-Cal beneficiaries,
especially high utilizers or those at risk of becoming high
utilizers.
2. Improving the capacity to provide point- of-care
services, complex care management, and population
health management by strengthening data analytic
capacity to drive system-level improvement and culturally
competent care
(Cont.)

1
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3. Improve population health and health outcomes as
evidenced by the achievement of performance goals
related to clinical improvements, effective preventive
interventions, and improved patient experience metrics
4. Improving the ability to furnish, in the most
appropriate setting, high-quality, care that integrates
physical and behavioral health services and coordinates
care in different settings for targeted vulnerable Medi-Cal
beneficiaries
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Three PRIME Domains
1.

Projects that will ensure that patients
experience timely access to high- quality,
efficient, and patient-centered care

2.

Targeted High-Risk or High-Cost Populations.

3.

Resource Utilization Efficiency.2

5. Moving participating PRIME entities towards valuebased payments through the adoption of alternative
payment models.2

• Projects that will ensure patients
experience timely access to high- quality,
efficient, and patient-centered care.
Domain 1: • Patients will receive appropriate
Projects that
preventive services, early diagnosis and
will ensure that
treatment, and will be supported in
patients
improving their ability to care for
experience
themselves.
timely access to • Identify and increase rates of costhigh-quality,
effective standard approaches to
efficient, and
prevention services for a select group of
patienthigh impact clinical conditions and
centered care.
populations (cardiovascular disease,
breast, cervical and colorectal cancer, and
obesity).

Domain 3:
Resource
Utilization
Efficiency.

• Projects that will reduce unwarranted
variation in the use of evidence-based,
diagnostics and treatments (antibiotics,
blood or blood products, and high cost
imaging studies and pharmaceutical
therapies) targeting overuse, misuse, as
well as inappropriate underuse of effective
interventions.
• Projects will also eliminate the use of
ineffective or harmful targeted clinical
services

Domain 2:
Targeted
High-Risk or
High-Cost
Populations.

• Projects focused on specific populations
that would benefit most significantly
from care integration and alignment
• Attention will be focused on managing
and coordinating care during transitions
from inpatient to outpatient and postacute settings, to optimize the care
experience and outcomes
• Improved Perinatal Care, Care
Transitions: Integration of Post-Acute
Care and Complex Care Management for
High Risk Medical Populations

PRIME and Cancer Screening
Ø Increasing Contra Costa Health Services
cervical cancer screening rates meets Goal 3
and Domain 1 of the PRIME Program.
Ø Continued funding from Medi-Cal 2020
waiver is crucial for CCHS to continue
providing high-quality services.

2
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Incidence and Mortality
• In

1975, the incidence of new cases of cervical
cancer was 14.8 per 100,000 persons.

• 2013:

Cervical Cancer

Screening Rates

estimated 12,990 new cases and 4, 120
deaths

• 5-year

survival rate if it is localized when
diagnosed is 91.3%, 57.4% if it is regional, and
16.8% if it is distant.7

Screening Tests
PRIME Benchmark

Current Rate

6.4 per 100,000 persons

• 2016:

Papanicolau (Pap) Test
• SurePath

for cytology

Target Goal

Screening Tests
HPV Test
• ThinPrep
• Never

alone

for HPV co-testing

screen with HPV testing

Screening Guidelines
United States Preventive Services Task Force 2012 Recommendations8

3
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Screening Guidelines
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Screening Guidelines

HPV testing is not recommended in
this age group.

Screening Guidelines

Screening Guidelines

Screening Considerations

Screening Considerations

Age Over 65
• Adequate prior screening

• High

 3 consecutive negative cytology results or
 2 consecutive negative HPV results within 10
years before cessation of screening, with the most
recent test occurring within 5 years.

Age Over 65
risk for cervical cancer

 HPV infection
 HIV infection
 Compromised immune system
 In utero exposure to diethylstilbestrol
 History high grade precancerous lesion or cervical
cancer

4
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Screening Guidelines

Age Over 65
• Routine screening should continue for at
least 20 years after spontaneous regression
or appropriate management of a high-grade
precancerous lesion, even if this extends
screening past age 65 years

Special Populations

•
•
•
•

Special Populations

HIV positive
organ transplantation
chemotherapy
chronic steroid therapy

Management of
Abnormal Pap
Smear
Age 21-24 years old

Follow-Up
How to manage abnormal Pap test results9

5
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Management
of Abnormal
Pap Smear
Age > 25 years old

What does this mean for you?
Your role in promoting cervical cancer screening

CHWs

Health Maintenance Review

• Review health

maintenance before
the visit
 When is the patient’s
next Pap due?
 Are they due at this
visit?

Don’t just rely on the dates you see

6
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Providers
• Is

the patient due for screening today?

• What
• How

are you screening for?

is it done?

Follow-Up
How to manage abnormal Pap test results9

Management of
Abnormal Pap
Smear
Age 21-24 years old

Management
of Abnormal
Pap Smear
Age > 25 years old

7
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Additional Health Maintenance
• For

women > 50 years
old, who have not had a
colonoscopy

• For

women age 50-74
years old who have not
had a mammogram
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Pocket Guide
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2012 USPSTF
Cervical Cancer Screening Guidelines*
Population
Women
< 21 years

Recommendation
Screening is not recommended.

Women
21 to 29
years

Screening with cytology only every 3 years.
HPV screening is not recommended, alone or
with cytology.

Women
30 to 65
years

Cytology (Pap smear) in combination with HPV
testing every 5 years or with cytology alone
every 3 years.

Women
> 65 years

Screening is not recommended if prior adequate
screeninga and are not considered high risk for
cervical cancerb.

Screening not recommended in women who
Women who
have had hysterectomy with the cervix removed
have had a
and no history of high-grade precancerous
hysterectomy
lesion (CIN 2 or 3) or cervical cancer.
*Does not apply to women who have received a diagnosis of a high-grade
precancerous cervical lesion or cervical cancer, women with in utero exposure
to diethylstilbestrol, or women who are immunocompromised (HIV positive,
organ transplantation, chemotherapy, chronic steroid therapy).
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Screening Considerations
a

Adequate prior screening is defined as:
• 3 consecutive negative cytology results or 2 consecutive
negative HPV results within 10 years before cessation of
screening, with the most recent test occurring within 5 years.
• Routine screening should continue for at least 20 years after
spontaneous regression or appropriate management of a
high-grade precancerous lesion, even if this extends
screening past age 65 years.

b

High Risk for Cervical Cancer:
•
HPV infection
•
HIV infection
•
Compromised immune system
•
In utero exposure to diethylstilbestrol (DES)
•
History high grade precancerous lesion or cervical cancer
Population

Recommendation
Cytology screening twice (every 6
Immunocompromised months) within the first year of
women
diagnosis. If both tests are normal,
resume annual screening.
Pregnant women

Screening with same frequency as
nonpregnant women.
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Management of Abnormal Results
21-24 years old
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Post-Colposcopy Follow-Up
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Post-Colposcopy Follow-Up
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Management of Abnormal Results
25 years or older
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Post-Colposcopy Follow-Up

74

INCREASING CERVICAL CANCER SCREENING RATES

Post-Colposcopy Follow-Up

(University
of Missouri
Department
Family
CommunityMedicine,
Medicine,2014)
2014)
(University
of Missouri
Department
of of
Family
&&
Community
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Appendix L
Patient Handout

Prevent Cervical Cancer
It’s time to get screened

Cervical Cancer is the abnormal growth of cells that starts in the cervix. It can
spread to other parts of the body if it is not treated. There may not be any signs
or symptoms early on. It is important to get screened to detect cervical cancer.
Screening

HPV

• When cervical cancer is found early, it is very
treatable and increases the chance of survival.
• There are two tests that screen for cervical cancer
ü The Pap test looks for changes in the cells of the
cervix. These changes can lead to cervical
cancer if left untreated.
ü The human papillomavirus (HPV) test looks for
the virus that can cause cell changes.

• HPV is a virus that is the main
cause of cervical cancer.
• It is a common virus passed
from one person to another
during sex.
• Most people get it, but it
typically goes away without
treatment.

The cervix is the lower, narrow end
of the uterus that connects the
uterus to the vagina.

When to get screened
Most women don’t need yearly Pap tests!
• Get your first Pap test at age 21
• If your results are normal, you don’t need to
be screened again for 3 years.
• When you turn 30 and if your results are
normal, you can get screened with a Pap test
and HPV test every 5 years.
• You can stop getting screened if:
ü
ü You are older
than 65 and have
had normal Pap
test results.

You do not need to be
screened if your cervix
was removed during a
surgery for a noncancerous condition.

Don’t wait until it’s too late! Call to schedule your Pap test
Appointment Unit: 1-800-495-8885
Financial Counselor: 1-800-771-4270
Your Pap test appointment is scheduled on: ____________
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Appendix M
Patient Handout in Spanish

Prevenga el cáncer de cuello uterino
Es el momento de hacerse las pruebas
El cáncer cervical es el crecimiento anormal de las células que se inicia en el cuello
del útero. Se puede propagar a otras partes del cuerpo si no es tratada. Puede que no
haya ningún signo o síntoma temprano. Es importante hacerse las pruebas para
detectar el cáncer de cuello uterino.
Las Pruebas
• Cuando se detecta el cáncer de cuello uterino temprano, es
muy tratable y aumenta las posibilidades de supervivencia.
• Existen dos exámenes que detectan el cáncer de cuello de
útero:
ü La prueba de Papanicolaou busca cambios en las
células del cuello uterino. Estos cambios pueden
conducir al cáncer cervical si no se tratan.
ü La prueba del virus del papiloma humano (VPH) busca
el virus que puede causar cambios en las células.

El cuello uterino es el extremo inferior
angosto del útero que conecta el útero
con la vagina.
Trompas de falopio
Ovario
s

Cuello
Uterin
o

Útero
Vagina

VPH
• El VPH es la causa principal del
cáncer de cuello uterino.
• El VPH es un virus muy común
que se transmite de persona a
persona durante las relaciones
sexuales.
• La mayoria de las personas
contraen este virus, pero
generalmente desaparece solo.
Cuándo hacerse pruebas

La mayoría de las mujeres no necesitan hacerse pruebas
de Papanicolau todos los anos!
• Hágase esta prueba por primera vez cuando tenga
21 años
• Si los resultados de su prueba son normales, puede
esperar 3 años antes de hacerse la próxima prueba
de Papanicoláu.
• Cuando cumpla 30 años y si los resultados de sus
pruebas son normales, puede hacerse las pruebas de
Papanicoláu y VPH cada 5 años
Puede dejar de hacerse pruebas de detección en los
siguientes casos
ü Es mayor de 65 años y

ha tenido resultados
normales de la prueba
de Papanicoláu.

ü Le extirparon el cuello

uterino quirúrgicamente
a causa de una afección
no cancerosa.

No espere hasta que sea demasiado tarde! Llame para
programar su prueba de Papanicolaou
Unidad de citas: 1-800-495-8885
Asesero financiero: 1-800-771-4270

Su cita para Papanicolaou es: ____________
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Appendix N
Cost Benefit Analysis

COSTS
- Estimated $1.5 billion in national expenditures
for cervical cancer care
- Inital care costs: $0.6 billion
- Continuing care costs: $0.2 billion
- Final care costs: $0.7 billion
- Lost productivity due to cervical cancer deaths:
$1.8 billion

BENEFITS
- Potential to save by reducing final year costs
- Screening with Pap test and HPV costs $200
- Improved quality of life with early detection
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Appendix O
Communication Plan

Author
Christina Nardi

DNP Chair

Co-chair

Prabjot Sandhu

Nancy Selix

Weekly email

Monthly or as needed

Contra Costa County
Weekly, in person or
email

In person, phone as needed

Public Health Clinic
Services Managers
Arlene Lin
Faculty Meeting

Michelle Sharman

Monthly

Weekly
PRIME Screening Leader
Heather Cedermaz
Bi-weekly in person, by email as needed
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Appendix P
Pre-Assessment
Role:

Provider

Nurse

CHW

Cervical Cancer Screening Pre-Assessment
Please rate on a scale of 1 to 5. 1-Strongly Disagree (SD), 2- Disagree D), 3- Neither agree or
disagree (N) 4-Agree (A), 5- Strongly Agree (SA)
SD

D

N

A

SA

1. I am confident in determining when the patient is
due for cervical cancer screening.

1

2

3

4

5

2. I am confident in determining what test(s) the
patient needs for cervical cancer screening.

1

2

3

4

5

3. I know the current cervical cancer screening
guidelines.

1

2

3

4

5

4. I routinely advise the patient when their next
cervical cancer screening is due.

1

2

3

4

5

5. A 20F comes to clinic requesting a Pap smear. She states that she is sexually active.
Based on the patient’s history she should
a. Get a Pap test today
b. Get a Pap test and HPV (co-test) today
c. Get a Pap test when she is 21 years old
d. Get a Pap test and HPV (co-test) until she is 21 years old
6. A 26F comes for Pap test. Her last Pap was normal 3 years ago. She should:
a. Get a Pap test today.
b. Get a Pap test and HPV (co-test) today.
c. Get a Pap and HPV (co-test) in 1 year.
7. A 45F comes to clinic for her Pap test. Her last Pap test was 3 years ago. She should
a. Get a Pap test today
b. Get a Pap test and HPV (co-test) today
c. Get a Pap test and HPV (co-test) in 2 years
d. A or B
8. A 68F comes to clinic requesting a Pap test. She has a history of 5 negative Pap tests
over the past 15 years. She should
a. Get a Pap test today
b. Get a Pap test and HPV (co-test) today
c. Discontinue getting Pap tests
9. A 50F comes to clinic requesting a Pap test. She had a hysterectomy with the cervix
removed 2 years ago. No history of cervical cancer or dysplasia. She should
a. Get a Pap test today
b. Get a Pap test and HPV (co-test) today
c. Discontinue getting Pap tests
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Appendix Q
Post-Assessment
Role:

Provider

Nurse

CHW

Cervical Cancer Screening Post-Assessment
Please rate on a scale of 1 to 5. 1-Strongly Disagree (SD), 2- Disagree D), 3- Neither agree or
disagree (N) 4-Agree (A), 5- Strongly Agree (SA)
SD

D

N

A

SA

1. I am confident in determining when the patient is
due for cervical cancer screening.

1

2

3

4

5

2. I am confident in determining what test(s) the
patient needs for cervical cancer screening.

1

2

3

4

5

3. I know the current cervical cancer screening
guidelines.

1

2

3

4

5

4. I routinely advise the patient when their next
cervical cancer screening is due.

1

2

3

4

5

5. A 20F comes to clinic requesting a Pap smear. She states that she is sexually active.
Based on the patient’s history she should
a. Get a Pap test today
b. Get a Pap test and HPV (co-test) today
c. Get a Pap test when she is 21 years old
d. Get a Pap test and HPV (co-test) when she is 21 years old
6. A 26F comes for Pap test. Her last Pap was normal 3 years ago. She should:
a. Get a Pap test today.
b. Get a Pap test and HPV (co-test) today.
c. Get a Pap and HPV (co-test) in 2 years.
7. A 45F comes to clinic for her Pap test. Her last Pap test was 3 years ago. She should
a. Get a Pap test today
b. Get a Pap test and HPV (co-test) today
c. Get a Pap test and HPV (co-test) in 2 years
d. A or B
8. A 68F comes to clinic requesting a Pap test. She has a history of 5 negative Pap tests
over the past 15 years. She should
a. Get a Pap test today
b. Get a Pap test and HPV (co-test) today
c. Discontinue getting Pap tests
9. A 50F comes to clinic requesting a Pap test. She had a hysterectomy with the cervix
removed 2 years ago. No history of cervical cancer or dysplasia. She should
a. Get a Pap test today
b. Get a Pap test and HPV (co-test) today
c. Discontinue getting Pap tests
(Turn Over)
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Evaluation
SD

D

N

A

SA

1. I found the presentation useful for my practice.

1

2

3

4

5

2. The presentation increased my understanding of
cervical cancer screening guidelines.

1

2

3

4

5

3. I am more likely to advise patients when their
next cervical cancer screening is due.

1

2

3

4

5

4. Annual guideline reviews would be helpful.

1

2

3

4

5

5. I think patient education materials would be
helpful for increasing screening rates.

1

2

3

4

5

Comments:
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Appendix R
Work Breakdown Structure

Cervical Cancer
Screening Toolkit

Initiation

Planning

Implementation

Evaluation

Literature Review

Evaluation of
evidence

Present PowerPoint

Compare pre- and
post-toolkit screening
rates

Form DNP committee

Develop project plan

Distribute pocket
guide at the clinics

Compare pre- and
post-test data

Submit Statement of
Determination for
Approval

Submit project plan
to committee

Distribute patient
handout in clinics

Meeting with
stakeholders

Milestone: Statement
of Determination
approved

Present project to
stakeholders

Milestone: Toolkit
completely
distributed

Editing toolkit as
needed for continued
use

Milestone: approval
of project plan from
DNP committee and
stakeholder
Creation of toolkit:
PowerPoint, pocket
guide, patient
handout

Milestone: approval
of toolkit
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Appendix S
GANTT Chart
2016
Deliverable/Month
Planning
Selection of Topic
Review of the literature
Submit Statement of Determination
Formation of DNP Committee
Present project to DNP Committee
Develop goals and objectives
Formalize project with
stakeholders, get letter of support
Creation of patient handout
Creation of PowerPoint and pocket
guide
Creation of staff assessment survey
Implementation
Presentation of PowerPoint
Evaluation
Analysis of pre- and postPowerPoint assessments
Analysis of cervical cancer
screening rates from SeptemberOctober 2015
Patient surveys regarding the
patient handout
Analysis of cervical cancer
screening rates from SeptemberOctober 2016
Presentation of findings to
University

Mar Apr May Jun July Aug Sep Oct Nov Dec
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Appendix T
Budget
Projected
Expenses

Actual
Expenses

135 hours

$8,433.45

$8,433.45

10 hours
5 hours

$582.42
$293.24

$582.42
$293.24

Pocket guide
• Printing

50 guides
$443.75

10 guides
$88.75

Patient handout
• Printing

200 handouts
$162.75

50 handouts
$40.69

20- $1,249. 40
25- $1,169.50
20- $412.60

9- $562.23
14- $654.92
11- $226.93

$12,747.11

$10,882.73

Direct Expenses
Hours
DNP student (project manager) at
$62.47/hr
Stakeholder meeting time
• Nurse Managers @ $58.24/hr
• PRIME FNP Leader @
$58.64/hr

Staff completion of pre- & posttoolkit assessments and PowerPoint at
meeting
• Family Nurse Practitioners*
• Registered Nurses*
• Community Health Workers
(CHWs)*

Estimated Total

1.0 hour per FNP,
RN, CHW

*The average hourly rate was used for the purposes of the proposed budget. Average hourly rate
is $62.47/hr for FNPs, $46.78/hr for RNs, and $20.63/hr for CHWs
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Patient Handout Assessment
Cervical Cancer Screening Pre Assessment
Age____________
Primary Language____________
1. What made you decide to make an appointment today?

2. Do you know how you are being screened?

3. Have you heard of HPV?

4. Do you know how HPV is related to cervical cancer?

5. How often do you need to be screened with a Pap test only?

6. How often do you need to be screened if you are tested with a Pap and HPV test?

7. If you don’t have abnormal results, at what age can you stop being screened?

Cervical Cancer Screening Post Assessment
1. How were you screened?

2. How is HPV related to cervical cancer?

3. How often do you need to be screened with a Pap test only?

4. How often do you need to be screened if you are tested with a Pap and HPV test?

5. If you don’t have abnormal results, at what age can you stop being screened?
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Appendix V
SWOT Analysis
Strengths

Weaknesses

Evidence supports the use of staff and patient
education in order to increase screening rates

Unable to control how many staff members
attend the meeting.

Full support from stakeholders and the PRIME
Cancer Screening team.

Success of the toolkit requires buy-in from
all staff members

Low cost of creating and implementing the
toolkit.

The initial implementation is only being
piloted with the PHCS staff and not all of
CCHS staff.

Ability to present to all staff at the monthly
meeting.

Need for continued updating of the pocket
reference.
Only available to patients already in the
clinic.

Opportunities
Increased cervical cancer screening rates can
improve health outcomes.

Threats
The author will not be present following
completion of the project to continue to
update the guidelines.

Possibility of presenting at all CCHS health
centers.

Lack of staff interest in the training.

Possibility of publishing the PowerPoint on an
eLearning system with yearly reviews

Possibility of staff not utilizing the toolkit
components.

Obtaining funding from the Medi-Cal 2020
waiver PRIME program.

All staff not completing the training and
learning about the toolkit.

Future development of additional toolkit
components for colorectal and breast cancer.
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Appendix W
Comparison of PHCS Provider Screening Rates

Cervical Cancer Screening Rates for
Public Health Clinic Services Providers
280

275

274

270
260
251
250
240

2016

239

230
220

September

2015

October
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Appendix X
Results of Pre and Post PowerPoint Staff Assessments

Questions 1-4
Staff Rating of Cerivcal Cancer Screening Practices
5
4.5
4
3.5
3
2.5
2
1.5
1
0.5
0

4.45

4.04

4.45

4.39

3.89

4

3.59

1. I am confident in
2. I am confident in
3. I know the current
determining when the determining what test(s) the cervical cancer screening
patient is due for cervical patient needs for cervical
guidelines.
cancer screening.
cancer screening.

Pre-Assessment

4.34

4. I routinely advise the
patient when their next
cervical cancer screening is
due.

Post-Assessment

On a scale of 1 to 5. 1-Strongly Disagree (SD), 2- Disagree (D), 3- Neither agree nor disagree
(N) 4-Agree (A), 5- Strongly Agree (SA)

Questions 5-9
Cervical Cancer Screening Scenarios
100%
90%
80%

91.18%

88.24%
74.07%

70%

97.06%
85.19%

74.07%
60.61%

60%
50%
33.33%

40%
30%

37.04%
29.41%

20%
10%
0%
Scenario Question 5

Scenario Question6

Scenario Question7 Scenario Question 8

Pre-Assessment

Post-Assessment

Scenario Question 9
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Appendix Y
Evaluation of PowerPoint Presentation
Question

Total Average Rating*

1. I found the presentation useful for my practice.

4.68

2. The presentation increased my understanding of cervical
cancer screening guidelines.

4.64

3. I am more likely to advise patients when their next cervical
cancer screening is due.

4.63

4. Annual guideline reviews would be helpful.

4.61

5. I think patient education materials would be helpful for
4.76
increasing screening rates.
*On a scale of 1 to 5. 1-Strongly Disagree (SD), 2- Disagree (D), 3- Neither agree nor disagree
(N) 4-Agree (A), 5- Strongly Agree (SA)

Evaluation of PowerPoint
5
4.9
4.8
4.7
4.6
4.5

4.91
4.77
4.704.68
4.50

4.73
4.62
4.56

4.64

4.73
4.62
4.54

4.62

4.73
4.69
4.61

4.77

4.76

4.56

4.33

4.4
4.3
4.2
4.1
4
1. I found the
2. The presentation 3. I am more likely to
presentation useful for
increased my
advise patients when
my practice.
understanding of
their next cervical
cervical cancer
cancer screening is
screening guidelines.
due.

Providers

Nurses

CHWs

4. Annual guideline
reviews would be
helpful.

5. I think patient
education materials
would be helpful for
increasing screening
rates.

Total Average

*On a scale of 1 to 5. 1-Strongly Disagree (SD), 2- Disagree (D), 3- Neither agree nor disagree
(N) 4-Agree (A), 5- Strongly Agree (SA)
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Appendix Z
Results of Patient Handout Pre and Post Assessments

Pre and Post Handout Patient Assessment
100%

100.0%

90%
75.0%

80%
70%

62.5%

75.0%

62.5%

60%
50%

37.5%

40%

25.0%

30%
20%

12.5%

10%

0.0%

0%
Have you heard of
HPV?

How is HPV related to How often do you
How often do you
At what age can you
cervical cancer?
need to get screened need to get screened
discontinue
with a Pap test only? with a Pap + HPV coscreening?
test?

Pre Assessment

Post Assessment

